Andra AP fonden Acquires 9,800 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Andra AP fonden increased its HCA Healthcare stake by 21.1% in the second quarter, acquiring 9,800 shares and bringing its total holdings to 56,323 shares valued at approximately $21.96 million.
• Institutional investors own 62.73% of HCA Healthcare, with BlackRock, Wellington Management, Capital World Investors, Geode Capital, and Norges Bank among the major holders that recently added or initiated positions.
• HCA exceeded quarterly earnings and revenue expectations, reporting $7.59 in EPS and $20.23 billion in revenue. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $462.27, while the company declared a quarterly dividend of $0.78 per share.

Andra AP fonden grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 56,323 shares of the company's stock after purchasing an additional 9,800 shares during the period. Andra AP fonden's holdings in HCA Healthcare were worth $21,960,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth $5,069,974,000. Capital World Investors increased its holdings in HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company's stock valued at $2,334,040,000 after buying an additional 40,086 shares during the period. Wellington Management Group LLP lifted its holdings in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock worth $1,835,397,000 after acquiring an additional 799,761 shares during the period. Geode Capital Management LLC increased its stake in HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock valued at $1,702,738,000 after acquiring an additional 13,565 shares during the last quarter. Finally, Norges Bank bought a new stake in HCA Healthcare during the fourth quarter worth $1,262,513,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

NYSE HCA traded up $10.98 during mid-day trading on Tuesday, reaching $436.95. 427,839 shares of the stock were exchanged, compared to its average volume of 1,358,292. The stock has a market cap of $94.60 billion, a P/E ratio of 14.63, a P/E/G ratio of 1.44 and a beta of 1.10. The stock has a 50 day simple moving average of $407.15 and a 200-day simple moving average of $428.24. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business's quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company posted $6.84 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.

Analyst Ratings Changes

Several brokerages recently weighed in on HCA. Sanford C. Bernstein restated a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. UBS Group reduced their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research note on Tuesday, July 7th. Finally, JPMorgan Chase & Co. lowered their target price on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a report on Thursday, August 20th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $462.27.

HCA Healthcare Profile

HCA Healthcare, Inc NYSE: HCA is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.